Management for prolactinomas of postmenopausal female patients: a retrospective single-center study

Xiaoxue Chen, Yixin Lu, Jiayu Liu, Xiaoan Ke, Hui Miao, Lian Duan, Fengying Gong, Hongbo Yang, Hui Pan, Linjie Wang, Huijuan Zhu · 2025

Read Management for prolactinomas of postmenopausal female patients: a retrospective single-center study by Xiaoxue Chen, Yixin Lu, Jiayu Liu, Xiaoan Ke, Hui Miao, Lian Duan, Fengying Gong, Hongbo Yang, Hui Pan, Linjie Wang, Huijuan Zhu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751742.txt.

Description

Chen and ten co-authors published a 2025 study of prolactinoma care in older women. These pituitary tumors make too much of the hormone prolactin. The team reviewed patients at one Beijing hospital from 2014 to 2024, split by whether diagnosis came before or after menopause. They focused on stopping dopamine agonist drugs in later life and on drug response in women diagnosed late.

Among 53 patients diagnosed before menopause, 35 tried stopping treatment and 16 relapsed, typically within six months, but all regained remission on retreatment. Higher hormone levels before stopping marked the relapse group. Six patients diagnosed late, mostly with small tumors, responded well to drugs. The authors call drug withdrawal promising after menopause, pending larger studies.

Catalog record

CREATORXiaoxue Chen, Yixin Lu, Jiayu Liu, Xiaoan Ke, Hui Miao, Lian Duan, Fengying Gong, Hongbo Yang, Hui Pan, Linjie Wang, Huijuan Zhu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12751742

Browse the full library · About the Tower of Babel